Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on January 15, 2007

Hypertension. 2007
Published online before print January 15, 2007, doi: 10.1161/01.HYP.0000255925.01707.eb
A more recent version of this article appeared on March 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
49/3/490    most recent
01.HYP.0000255925.01707.ebv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chao, J.
Right arrow Articles by Chao, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chao, J.
Right arrow Articles by Chao, L.
Related Collections
Right arrow Animal models of human disease

Submitted on August 23, 2006
Revised on September 15, 2006

Kinin Infusion Prevents Renal Inflammation, Apoptosis, and Fibrosis via Inhibition of Oxidative Stress and Mitogen-Activated Protein Kinase Activity

Julie Chao; Huey-Jiun Li; Yu-Yu Yao; Bo Shen; Lin Gao; Grant Bledsoe; and Lee Chao*

From the Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston.

* To whom correspondence should be addressed. E-mail: chaol{at}musc.edu.

Abstract--The progression of renal disease displays several characteristics, including proteinuria, apoptosis, inflammation, and fibrosis. In this study, we investigated the effect of long-term infusion of kinin in protection against salt-induced renal damage in Dahl salt-sensitive rats. Dahl salt-sensitive rats were fed a high-salt diet for 2 weeks and were then infused with bradykinin (500 ng/h) via subcutaneously implanted minipumps for 3 weeks. Kinin infusion attenuated salt-induced impaired renal function as evidenced by reduced proteinuria, serum creatinine, and blood urea nitrogen levels without apparent effect on blood pressure. Morphological analysis indicated that kinin administration reduced salt-induced glomerular sclerosis, tubular dilatation, luminal protein cast formation, and interlobular arterial thickness. Kinin also significantly lowered collagen I, III, and IV deposition and their mRNA levels. Moreover, kinin reduced interstitial monocyte/macrophage accumulation, as well as tubular cell apoptosis and caspase-3 activity. Protection of renal injury by kinin was associated with increased renal NO levels and reduced nicotinamide adenine dinucleotide/nicotinamide adenine dinucleotide phosphate oxidase activities and superoxide generation. Suppression of oxidative stress by kinin was accompanied by reduced transforming growth factor-{beta}1 protein and mRNA levels, as well as decreased phosphorylation of mitogen-activated protein kinases. This is the first study to demonstrate that kinin infusion can directly protect against salt-induced renal injury without blood pressure reduction by inhibiting apoptosis, inflammation, and fibrosis via suppression of oxidative stress, transforming growth factor-{beta}1 expression, and mitogen-activated protein kinase activation.


Key words: kinin • fibrosis • kidney • oxidative stress • inflammation • apoptosis • mitogen-activated protein kinases




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
A. M. Marney, J. Ma, J. M. Luther, T. A. Ikizler, and N. J. Brown
Endogenous Bradykinin Contributes to Increased Plasminogen Activator Inhibitor 1 Antigen following Hemodialysis
J. Am. Soc. Nephrol., October 1, 2009; 20(10): 2246 - 2252.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
J. Xu, O. A. Carretero, E. G. Shesely, N.-E. Rhaleb, J. J. Yang, M. Bader, and X.-P. Yang
The kinin B1 receptor contributes to the cardioprotective effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in mice
Exp Physiol, March 1, 2009; 94(3): 322 - 329.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Buleon, J. Allard, A. Jaafar, F. Praddaude, Z. Dickson, M.-T. Ranera, C. Pecher, J.-P. Girolami, and I. Tack
Pharmacological blockade of B2-kinin receptor reduces renal protective effect of angiotensin-converting enzyme inhibition in db/db mice model
Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1249 - F1256.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Shen, M. Hagiwara, Y.-Y. Yao, L. Chao, and J. Chao
Salutary Effect of Kallistatin in Salt-Induced Renal Injury, Inflammation, and Fibrosis via Antioxidative Stress
Hypertension, May 1, 2008; 51(5): 1358 - 1365.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. Allard, M. Buleon, E. Cellier, I. Renaud, C. Pecher, F. Praddaude, M. Conti, I. Tack, and J.-P. Girolami
ACE inhibitor reduces growth factor receptor expression and signaling but also albuminuria through B2-kinin glomerular receptor activation in diabetic rats
Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1083 - F1092.
[Abstract] [Full Text] [PDF]